Compare Stocks

→ The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNAA Social Capital Suvretta Holdings Corp. I	$14.07	$11.74	$9.07 ▼ $17.44	$360.76M	-0.02	182,488 shs	4.63 million shs
DNAB Social Capital Suvretta Holdings Corp. II	$10.35 +0.1%	$10.33	$9.70 ▼ $11.02	$330.06M	0.02	120,368 shs	142,500 shs
FST FAST Acquisition	$10.18	$10.19	$10.01 ▼ $13.17	$254.50M	0.17	192,412 shs	1.76 million shs
ORIA Orion Biotech Opportunities	$10.23	$9.72	$9.45 ▼ $10.78	$263.42M	-0.01	13,059 shs	8 shs
SWAG Stran & Company, Inc.	$1.16 -1.7%	$1.40	$0.91 ▼ $1.74	$21.59M	2.22	21,898 shs	17,561 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNAA Social Capital Suvretta Holdings Corp. I	0.00%	0.00%	0.00%	0.00%	0.00%
DNAB Social Capital Suvretta Holdings Corp. II	0.00%	0.00%	0.00%	0.00%	+0.88%
FST FAST Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
ORIA Orion Biotech Opportunities	0.00%	0.00%	0.00%	0.00%	-0.20%
SWAG Stran & Company, Inc.	-0.84%	-2.48%	-17.48%	-28.48%	-24.84%

The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DNAA Social Capital Suvretta Holdings Corp. I	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DNAB Social Capital Suvretta Holdings Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FST FAST Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ORIA Orion Biotech Opportunities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SWAG Stran & Company, Inc.	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNAA Social Capital Suvretta Holdings Corp. I	N/A	N/A	N/A	N/A
DNAB Social Capital Suvretta Holdings Corp. II	N/A	N/A	N/A	N/A
FST FAST Acquisition	N/A	N/A	N/A	N/A
ORIA Orion Biotech Opportunities	N/A	N/A	N/A	N/A
SWAG Stran & Company, Inc.	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNAA Social Capital Suvretta Holdings Corp. I	N/A	N/A	N/A	N/A	($0.33) per share	N/A
DNAB Social Capital Suvretta Holdings Corp. II	N/A	N/A	$0.09 per share	120.33	($0.23) per share	N/A
FST FAST Acquisition	N/A	N/A	N/A	N/A	($0.69) per share	N/A
ORIA Orion Biotech Opportunities	N/A	N/A	$0.34 per share	30.08	($0.30) per share	N/A
SWAG Stran & Company, Inc.	$75.89M	0.28	$0.08 per share	14.22	$2.13 per share	0.54

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNAA Social Capital Suvretta Holdings Corp. I	-$2.44M	N/A	0.00	∞	N/A	N/A	N/A	-3.32%	N/A
DNAB Social Capital Suvretta Holdings Corp. II	$2.74M	N/A	0.00	∞	N/A	N/A	-73.34%	2.13%	N/A
FST FAST Acquisition	-$40.56M	N/A	0.00	∞	N/A	N/A	-70.91%	19.85%	N/A
ORIA Orion Biotech Opportunities	$8.76M	N/A	0.00	∞	N/A	N/A	-110.40%	4.34%	N/A
SWAG Stran & Company, Inc.	$40K	-$0.02	N/A	∞	N/A	0.05%	0.09%	0.06%	5/20/2024 (Estimated)

Latest DNAB, DNAA, SWAG, FST, and ORIA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/28/2024	Q4 2023	SWAG Stran & Company, Inc.	N/A	$0.03	+$0.03	$0.03	N/A	$23.34 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNAA Social Capital Suvretta Holdings Corp. I	N/A	N/A	N/A	N/A	N/A
DNAB Social Capital Suvretta Holdings Corp. II	N/A	N/A	N/A	N/A	N/A
FST FAST Acquisition	N/A	N/A	N/A	N/A	N/A
ORIA Orion Biotech Opportunities	N/A	N/A	N/A	N/A	N/A
SWAG Stran & Company, Inc.	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNAA Social Capital Suvretta Holdings Corp. I	N/A	0.09	0.09
DNAB Social Capital Suvretta Holdings Corp. II	N/A	0.98	0.98
FST FAST Acquisition	N/A	0.70	0.70
ORIA Orion Biotech Opportunities	N/A	6.49	6.49
SWAG Stran & Company, Inc.	0.12	2.94	2.55

Ownership

Institutional Ownership

Company	Institutional Ownership
DNAA Social Capital Suvretta Holdings Corp. I	N/A
DNAB Social Capital Suvretta Holdings Corp. II	76.58%
FST FAST Acquisition	50.59%
ORIA Orion Biotech Opportunities	56.30%
SWAG Stran & Company, Inc.	56.42%

Insider Ownership

Company	Insider Ownership
DNAA Social Capital Suvretta Holdings Corp. I	N/A
DNAB Social Capital Suvretta Holdings Corp. II	N/A
FST FAST Acquisition	1.26%
ORIA Orion Biotech Opportunities	2.40%
SWAG Stran & Company, Inc.	53.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DNAA Social Capital Suvretta Holdings Corp. I	4	25.64 million	N/A	Not Optionable
DNAB Social Capital Suvretta Holdings Corp. II	4	31.89 million	N/A	Not Optionable
FST FAST Acquisition	N/A	25.00 million	24.69 million	Not Optionable
ORIA Orion Biotech Opportunities	2,021	25.75 million	25.13 million	Not Optionable
SWAG Stran & Company, Inc.	118	18.61 million	8.67 million	Not Optionable

DNAB, DNAA, SWAG, FST, and ORIA Headlines

Source	Headline
	Software Acquisition Group Inc. III (NASDAQ:SWAG) Q4 2023 Earnings Call Transcript finance.yahoo.com - April 1 at 8:48 PM
	Stran & Company, Inc.: Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year finanznachrichten.de - March 29 at 5:16 AM
	Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year globenewswire.com - March 28 at 7:00 AM
	Stran & Company Schedules Fiscal 2023 Year Financial Results and Business Update Conference Call globenewswire.com - March 19 at 9:00 AM
	Stran & Co Inc SWAG morningstar.com - February 15 at 12:38 AM
	Stran & Company Secures Multi-Year Agreement with One of the World’s Leading Global Professional Services Firms finance.yahoo.com - February 12 at 9:48 AM
	Stran & Company Secures Multi-Year Agreement with One of the World’s Leading Global Professional Services Firms finance.yahoo.com - February 12 at 9:48 AM
	Stran & Company, Inc.: Stran & Company Appoints Ian Thomas Wall as Chief Information Officer finanznachrichten.de - January 4 at 3:10 PM
	Stran & Company Appoints Ian Thomas Wall as Chief Information Officer finance.yahoo.com - January 4 at 10:09 AM
	Stran & Company Expands Executive Sales Team with the Addition of Two Industry Veterans markets.businessinsider.com - December 22 at 12:34 PM
	Stran & Company Expands Executive Sales Team with the Addition of Two Industry Veterans finance.yahoo.com - December 22 at 12:34 PM
	Stran & Company to Present at the Investor Summit on December 7th finance.yahoo.com - December 4 at 10:26 AM
	Software Acquisition Group Inc. III (NASDAQ:SWAG) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 12 at 8:42 AM
	Stran & Company to Present at the Sidoti Virtual Investor Conference on November 16th finance.yahoo.com - November 10 at 12:12 PM
	Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement finance.yahoo.com - November 7 at 8:00 AM
	Stran & Company Announces 42% Increase in Revenue and Reports Profitable Net Earnings for the Third Quarter of 2023 markets.businessinsider.com - November 6 at 10:02 AM
	Stran & Company Announces 42% Increase in Revenue and Reports Profitable Net Earnings for the Third Quarter of 2023 finance.yahoo.com - November 6 at 10:02 AM
	Stran & Company Schedules Third Quarter 2023 Financial Results and Business Update ... bakersfield.com - October 31 at 2:14 PM
	Stran & Company Schedules Third Quarter 2023 Financial Results and Business Update Conference Call finance.yahoo.com - October 31 at 9:14 AM
	Andy Shape, CEO of Stran & Company, Ranked 24th on 2023 List of Most Powerful People in the Promotional Products Industry finance.yahoo.com - October 27 at 11:42 AM
	Stran & Company Secures Six-Figure, Multi-Year Contract with a Leading Medical Group Specializing in the Treatment of Gastrointestinal Disorders finance.yahoo.com - October 19 at 1:16 PM
	Stran & Co Inc (SWAG) investing.com - September 21 at 7:54 PM
	Stran & Company Appoints Experienced Information Technology Strategist, David Leuci, as Chief Information Officer markets.businessinsider.com - September 21 at 8:43 AM
	Stran & Company Appoints Experienced Information Technology Strategist, David Leuci, as Chief Information Officer finance.yahoo.com - September 19 at 10:49 AM

Media Sentiment Over Time

Company Descriptions

Social Capital Suvretta Holdings Corp. I

NASDAQ:DNAA

Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.

Social Capital Suvretta Holdings Corp. II

NASDAQ:DNAB

Social Capital Suvretta Holdings Corp. II does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in biotechnology industry. Social Capital Suvretta Holdings Corp. II was incorporated in 2021 and is based in Henderson, Nevada.

FAST Acquisition

NYSE:FST

FAST Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in restaurant, hospitality, and related sectors. FAST Acquisition Corp. was incorporated in 2020 and is based in Ridgefield, Connecticut.

Orion Biotech Opportunities

NASDAQ:ORIA

Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.

Stran & Company, Inc.

NASDAQ:SWAG

Stran & Company, Inc. provides outsourced marketing solutions. The company offers clients custom sourcing services; and e-commerce solutions for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral and event assets, order and inventory management, designing and hosting online retail popup shops, fixed public retail online stores, and online business-to-business service offerings. It also provides creative and merchandising services; warehousing/fulfillment and distribution; print-on-demand services; kitting services; point of sale displays; and loyalty and incentive programs. The company was founded in 1994 and is headquartered in Quincy, Massachusetts.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial